Jilong Yang

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 13

Top Topics

Squamous Cell Carcinoma

Signaling Pathway

Ejection Fraction

Top Venues

Cancer biology & medicine

Cell death discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Gengpu Zhang, Shengnan Li, Wanyi Xiao, Chao Zhang, Ting Li, Zhichao Liao, Haotian Liu, Ruwei Xing, Wei Yao, Jilong Yang
Tumoral C2 Regulates the Tumor Microenvironment by Increasing the Ratio of M1/M2 Macrophages and Tertiary Lymphoid Structures to Improve Prognosis in Melanoma. Cancers 16 (5) (2024)
Gengpu Zhang, Shengnan Li, Wanyi Xiao, Chao Zhang, Ting Li, Zhichao Liao, Haotian Liu, Ruwei Xing, Wei Yao, Jilong Yang
Tumoral C2 Regulates the Tumor Microenvironment by Increasing the Ratio of M1/M2 Macrophages and Tertiary Lymphoid Structures to Improve Prognosis in Melanoma. Cancers 16 (5) (2024)
Peipei Xing, Haotian Liu, Wanyi Xiao, Gengpu Zhang, Chao Zhang, Zhichao Liao, Ting Li, Jilong Yang
The fusion gene LRP1-SNRNP25 drives invasion and migration by activating the pJNK/37LRP/MMP2 signaling pathway in osteosarcoma. Cell death discovery 10 (1) (2024)
Peipei Xing, Haotian Liu, Wanyi Xiao, Gengpu Zhang, Chao Zhang, Zhichao Liao, Ting Li, Jilong Yang
The fusion gene LRP1-SNRNP25 drives invasion and migration by activating the pJNK/37LRP/MMP2 signaling pathway in osteosarcoma. Cell death discovery 10 (1) (2024)
Jilong Yang, Jin Xu, Haotian Liu, Wanyi Xiao, Gengpu Zhang
Deep insight into the B-cell associated tertiary lymphoid structure and tumor immunotherapy. Cancer biology & medicine (2023)
Jilong Yang, Yu Xu, Yong Chen, Tao Li, Xiaowei Zhang, Tu Hu, Ruwei Xing, Yun Yang
Therapeutic perspectives for adult soft tissue sarcoma-updates from the 2022 ASCO annual meeting. Cancer biology & medicine 19 (10) (2022)
Chao Zhang, Hongru Shen, Tielong Yang, Ting Li, Xinyue Liu, Jin Wang, Zhichao Liao, Junqiang Wei, Jia Lu, Haotian Liu, Lijie Xiang, Yichen Yang, Meng Yang, Duan Wang, Yang Li, Ruwei Xing, Sheng Teng, Jun Zhao, Yun Yang, Gang Zhao, Ke-Xin Chen, XiangChun Li, Jilong Yang
A single-cell analysis reveals tumor heterogeneity and immune environment of acral melanoma. Nature communications 13 (1) (2022)
Jia Lu, Ting Li, Zhichao Liao, Hui Yu, Yongtian Zhao, Haixiao Wu, Zhiwu Ren, Jun Zhao, Ruwei Xing, Sheng Teng, Yun Yang, Xiangchun Li, Kexin Chen, Jonathan C Trent, Jilong Yang
The efficacies and biomarker investigations of antiprogrammed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma. Cancer biology & medicine (2021)
Zhichao Liao, Ting Li, Chao Zhang, Xinyue Liu, Ruwei Xing, Sheng Teng, Yun Yang, Gang Zhao, Xu Bai, Jun Zhao, Jilong Yang
Clinical study of apatinib in the treatment of stage IV osteogenic sarcoma after failure of chemotherapy. Cancer biology & medicine 17 (2) (2021)
Haotian Liu, Nahar Nazmun, Shafat Hassan, Xinyue Liu, Jilong Yang
BRAF mutation and its inhibitors in sarcoma treatment. Cancer medicine 9 (14) (2020)
Peng Gao, Dan Wang, Meiyue Liu, Siyuan Chen, Zhao Yang, Jie Zhang, Huan Wang, Yi Niu, Wei Wang, Jilong Yang, Guogui Sun
DNA methylation-mediated repression of exosomal miR-652-5p expression promotes oesophageal squamous cell carcinoma aggressiveness by targeting PARG and VEGF pathways. PLoS genetics 16 (4) (2020)
Zhichao Liao, Feng Li, Chao Zhang, Lei Zhu, Yehui Shi, Gang Zhao, Xu Bai, Shafat Hassan, Xinyue Liu, Ting Li, Peipei Xing, Jun Zhao, Jin Zhang, Ruwei Xing, Sheng Teng, Yun Yang, Kexin Chen, Jilong Yang
Phase II trial of VEGFR2 inhibitor apatinib for metastatic sarcoma: focus on efficacy and safety. Experimental & molecular medicine 51 (3) (2019)
Zhichao Liao, Minghan Qiu, Jilong Yang, Yun Yang, Lei Zhu, Bo Yang, Xu Bai, Peipei Xing, Jin Zhang, Ruwei Xing, Sheng Teng, Jun Zhao
Outcomes of surgery and/or combination chemotherapy for extraskeletal osteosarcoma: a single-center retrospective study from China. Scientific reports 9 (1) (2019)